Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05627986
Other study ID # YM111008F
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 14, 2022
Est. completion date August 31, 2024

Study information

Verified date March 2023
Source National Yang Ming University
Contact Yin-Liang Lin, PhD
Phone +886-2-2826-7288
Email yinliang@ym.edu.tw
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Shoulder pain is a common musculoskeletal system complaint, accounting for 7-34% of patients in the clinic. The most common shoulder problem is subacromial impingement syndrome (SIS). Up to 45% of individuals with SIS may have unsuccessful treatment and still complain of symptoms after 2 years. This chronicity of pain may not be fully explained by structural injuries or damage, but may be related to sensorimotor changes. Decreased corticospinal excitability and increase inhibition have been found in individuals with SIS. These central motor changes may link to alteration in pain and nociception processing and the somatosensory system, which has been found in individuals with low back pain. Hyperalgesia has been found over both affected and unaffected shoulders in patients with SIS, indicating central and peripheral sensitization. However, no study has investigated whether there are changes in the central somatosensory system. Therefore, the objectives of this proposal are (1) to investigate the corticomotor and somatosensory system in patients with SIS (2) to investigate the relationship between the corticomotor and somatosensory alterations in patients with SIS. Subjects with chronic SIS and healthy subjects were recruited, with 32 people in each group. Electroencephalography (EEG) will be used to collect somatosensory activity, including somatosensory evoked potentials, spectral analysis of EEG oscillations and event-related spectral perturbation (ERSP) of the shoulder movement. Electromyography will be used to record muscle activity. Transcranial magnetic stimulation will be used to test corticomotor excitability, including active motor threshold, motor evoked potentials, cortical silent period, and intracortical inhibition and facilitation. The pressure pain threshold will be collected by a pressure algometer on the muscles of bilateral arms and legs. Pain intensity will be assessed with the Numeric Rating Scale. Shoulder function will be evaluated with the Disability of Arm, Shoulder and Hand questionnaire. Depression will be evaluated with Center for Epidemiologic Studies Depression Scale (CES-D).


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date August 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria (chronic impingement syndrome group): 1. individuals have shoulder pain localized at the anterior or lateral aspect of shoulder more than six months 2. are aged 20 to 65 years old 3. shoulder impingement syndrome, which is confirmed by having at least three of the following: (a) positive Neer's test, (b) positive Hawkins-Kennedy test, (c) positive empty can test, (d) positive resisted external rotation test, and (e) presenting painful arc during arm elevation Inclusion Criteria (acute/subacute impingement syndrome group): 1. individuals have shoulder pain localized at the anterior or lateral aspect of shoulder less than six months 2. are aged 20 to 65 years old 3. shoulder impingement syndrome, which is confirmed by having at least three of the following: (a) positive Neer's test, (b) positive Hawkins-Kennedy test, (c) positive empty can test, (d) positive resisted external rotation test, and (e) presenting painful arc during arm elevation Inclusion Criteria (health control group) 1. individuals without any shoulder and neck problems 2. sex, age, and hand dominance match to impingement group Exclusion Criteria: 1. have a history of dislocation, fracture, adhesive capsulities, or surgery of upper extremity 2. arm elevation angle less than 150 degrees 3. a history of direct contact injury to the neck or upper extremities within the past 12 months 4. brain injury and neurological impairment 5. inflammatory cause of the pain (e.g., rheumatoid arthritis) 6. neck pain 7. psychosis and symptom of headache or dizziness 8. allergy to plaster 9. contraindications to the use of TMS, assessed with a safety screening questionnaire

Study Design


Intervention

Other:
No intervention
No intervention

Locations

Country Name City State
Taiwan National Yang Ming Chiao Tung University Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Yang Ming University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Corticomotor excitability measures - Active motor threshold Active motor threshold (AMT) will be described with the percentage (%) of maximum stimulator output (MSO). Immediately during the experiment
Primary Corticomotor excitability measures - Motor evoked potential Motor evoked potential (MEP) will be described with millivolt (mV). Immediately during the experiment
Primary Corticomotor excitability measures - Cortical silent period Cortical silent period (CSP) will be measured with millisecond (ms) Immediately during the experiment
Primary Corticomotor excitability measures - Short interval cortical inhibition Short interval cortical inhibition (SICI) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is below 5 ms Immediately during the experiment
Primary Corticomotor excitability measures - Short interval cortical facilitation Short interval cortical facilitation (SICF) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is above 5 ms Immediately during the experiment
Primary Corticomotor excitability measures - Long-interval intracortical inhibition Long-interval intracortical inhibition (LICI) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is below 5 ms Immediately during the experiment
Primary Corticomotor excitability - Area of cortical mapping Area of cortical mapping will be described with square millimeter (mm2) Immediately during the experiment
Primary Corticomotor excitability - Volume of cortical mapping Volume of cortical mapping will be calculated with multiplying summation of motor evoke potentials on the map (mV) by the area of the map (mm2) with the unit of mV*mm2 Immediately during the experiment
Primary Corticomotor excitability - Center of gravity of cortical mapping Center of gravity of cortical mapping will be described in a x-y coordinate system (mm). Immediately during the experiment
Primary Resting brain activity - resting EEG with eye open/closed EEG signals will be processed with power spectrum density analysis to calculate frequency power at Theta (3-8 Hz), alpha (8-13 Hz), beta (13-30 Hz) bands, and Gamma (30 Hz above). Immediately during the experiment
Primary Somatosensory cortical activity - Somatosensory evoked potentials Somatosensory evoked potentials (SEP) will be described with microvolt (µV) and millisecond (ms). Immediately during the experiment
Primary Event-related synchronization or desynchronization - Movement evoked pain potentials Movement evoked pain potentials will be processed with power spectrum density analysis to calculate frequency power at Theta (3-8 Hz), alpha (8-13 Hz), beta (13-30 Hz) bands, and Gamma (30 Hz above) while raising hand. Immediately during the experiment
Primary Muscle activation during arm elevation The root mean square of electromyography (EMG) data of the anterior deltoid and infraspinatus will be normalized by the maximum voluntary contraction amplitude (percentage of maximal voluntary contraction, %) and calculated in two segments, including arm elevating and arm lowering. Immediately during the experiment
Secondary Shoulder pain and function-Taiwan version of the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire Subjects will be asked 30 items related to shoulder functional movement. The overall score ranges from 0 (no disability) to 100 (most severe disability). Immediately during the experiment
Secondary Depression- Taiwan version of the Center for Epidemiologic Studies Depression Scale (CES-D) Subjects will be asked 20 items to rate how often over the past week they experienced symptoms associated with depression. Response options range from 0 to 3 for each item. Scores range from 0 to 60, with high scores indicating greater depressive symptoms. Immediately during the experiment
Secondary Pressure pain thresholds Pressure pain threshold of bilateral upper trapezius, levator scapulae, infraspinatus, pectoralis major, biceps brachii, middle deltoid and tibialis anterior will each be averaged and will be described with kg/cm2. Immediately during the experiment
Secondary Electrical sensory threshold Electrical sensory threshold is the minimal intensity of stimulation required to produce the first perception of sensory and will be described with millivolts (mV). Immediately during the experiment
Secondary Electrical pain threshold Electrical pain threshold is the minimal intensity of stimulation required to produce the first perception of pain and will be described with millivolts (mV). Immediately during the experiment
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
Completed NCT05036499 - PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain N/A